Pulmonary function tests, interstitial lung disease and lung function decline in outpatients with classic and clinically amyopathic dermatomyositis.
作者信息
George M D, Shah R, Kreider M, Miller W T, Merkel P A, Werth V P
机构信息
Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, U.S.A.
Division of Pulmonary & Critical Care Medicine, University of Pennsylvania, Philadelphia, PA, U.S.A.
出版信息
Br J Dermatol. 2017 Jan;176(1):262-264. doi: 10.1111/bjd.14771. Epub 2016 Dec 7.
Abstract
摘要
相似文献
1
Pulmonary function tests, interstitial lung disease and lung function decline in outpatients with classic and clinically amyopathic dermatomyositis.
Br J Dermatol. 2017 Jan;176(1):262-264. doi: 10.1111/bjd.14771. Epub 2016 Dec 7.
2
Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis.
Chest. 2009 Nov;136(5):1341-1347. doi: 10.1378/chest.08-2740. Epub 2009 Jul 6.
3
Amyopathic Dermatomyositis Associated with Histopathological Findings of Organizing Pneumonia and Pulmonary Vasculitis.
Balkan Med J. 2017 Aug 4;34(4):374-377. doi: 10.4274/balkanmedj.2016.1061. Epub 2017 Apr 13.
4
Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis Complicated by Unilateral Right-sided Interstitial Lung Disease.
Intern Med. 2020;59(3):401-408. doi: 10.2169/internalmedicine.3604-19. Epub 2020 Feb 1.
5
Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
Respir Investig. 2017 Mar;55(2):130-137. doi: 10.1016/j.resinv.2016.09.006. Epub 2017 Feb 8.
6
Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients.
Rheumatology (Oxford). 2014 Apr;53(4):644-9. doi: 10.1093/rheumatology/ket380. Epub 2013 Dec 5.
7
Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.
Rheumatology (Oxford). 2005 Oct;44(10):1282-6. doi: 10.1093/rheumatology/keh723. Epub 2005 Jun 21.
8
Amyopathic Dermatomyositis: A Concise Review of Clinical Manifestations and Associated Malignancies.
Am J Clin Dermatol. 2016 Oct;17(5):509-518. doi: 10.1007/s40257-016-0199-z.
9
Novel associations between cytokines and pulmonary involvement in juvenile dermatomyositis - a cross-sectional study of long-term disease.
Rheumatology (Oxford). 2020 Aug 1;59(8):1862-1870. doi: 10.1093/rheumatology/kez531.
10
Potentially fatal interstitial lung disease can occur in clinically amyopathic dermatomyositis.
J Am Acad Dermatol. 2003 May;48(5):797-8. doi: 10.1067/mjd.2003.199.
引用本文的文献
1
Dermatomyositis: focus on cutaneous features, etiopathogenetic mechanisms and their implications for treatment.
Semin Immunopathol. 2025 Aug 6;47(1):32. doi: 10.1007/s00281-025-01054-9.
2
Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis.
Int J Womens Dermatol. 2021 Sep 24;7(5Part A):583-587. doi: 10.1016/j.ijwd.2021.09.002. eCollection 2021 Dec.
3
Clinical Characteristics and Management of Patients With Clinical Amyopathic Dermatomyositis: A Retrospective Study of 64 Patients at a Tertiary Dermatology Department.
Front Med (Lausanne). 2021 Dec 2;8:783416. doi: 10.3389/fmed.2021.783416. eCollection 2021.
4
MDA5 autoantibody-another indicator of clinical diversity in dermatomyositis.
Ann Transl Med. 2017 Apr;5(7):160. doi: 10.21037/atm.2017.03.94.
本文引用的文献
1
Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.
Arthritis Care Res (Hoboken). 2016 May;68(5):689-94. doi: 10.1002/acr.22728.
2
Prognostic factors for myositis-associated interstitial lung disease.
PLoS One. 2014 Jun 6;9(6):e98824. doi: 10.1371/journal.pone.0098824. eCollection 2014.
3
Pulmonary manifestations of polymyositis/dermatomyositis.
Semin Respir Crit Care Med. 2014 Apr;35(2):239-48. doi: 10.1055/s-0034-1371528. Epub 2014 Mar 25.
4
Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody.
Arthritis Care Res (Hoboken). 2012 Oct;64(10):1602-10. doi: 10.1002/acr.21728.
5
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
6
Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations.
Arch Dermatol. 2010 Jul;146(7):729-38. doi: 10.1001/archdermatol.2010.134.
7
Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis.
Chest. 2009 Nov;136(5):1341-1347. doi: 10.1378/chest.08-2740. Epub 2009 Jul 6.
8
Interstitial lung disease in polymyositis and dermatomyositis.
Clin Rheumatol. 2009 Jun;28(6):639-46. doi: 10.1007/s10067-009-1110-6. Epub 2009 Feb 27.
9
Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.
Rheumatology (Oxford). 2005 Oct;44(10):1282-6. doi: 10.1093/rheumatology/keh723. Epub 2005 Jun 21.
10
Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects.
Dermatol Clin. 2002 Jul;20(3):387-408. doi: 10.1016/s0733-8635(02)00021-9.
Zotero 插件